These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 24333394

  • 1. Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model.
    Dwyer MG, Bergsland N, Zivadinov R.
    Neuroimage; 2014 Apr 15; 90():207-17. PubMed ID: 24333394
    [Abstract] [Full Text] [Related]

  • 2. SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI.
    Battaglini M, Jenkinson M, De Stefano N, Alzheimer's Disease Neuroimaging Initiative.
    Hum Brain Mapp; 2018 Mar 15; 39(3):1063-1077. PubMed ID: 29222814
    [Abstract] [Full Text] [Related]

  • 3. Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up study.
    Dolezal O, Gabelic T, Horakova D, Bergsland N, Dwyer MG, Seidl Z, Krasensky J, Ramasamy DP, Vaneckova M, Havrdova E, Zivadinov R.
    Clin Neurol Neurosurg; 2013 Dec 15; 115 Suppl 1():S42-8. PubMed ID: 24321154
    [Abstract] [Full Text] [Related]

  • 4. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M, Buck D, Förschler A, Boucard CC, Arsic M, Schmidt P, Gaser C, Berthele A, Hoshi M, Jochim A, Kronsbein H, Zimmer C, Hemmer B, Ilg R.
    Mult Scler; 2013 Oct 15; 19(11):1485-92. PubMed ID: 23462349
    [Abstract] [Full Text] [Related]

  • 5. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    Battaglini M, Giorgio A, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N.
    J Neurol Sci; 2009 Jul 15; 282(1-2):55-60. PubMed ID: 19286193
    [Abstract] [Full Text] [Related]

  • 6. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E, Lee JC, Nakamura K, Rudick RA.
    Ann Neurol; 2008 Sep 15; 64(3):255-65. PubMed ID: 18661561
    [Abstract] [Full Text] [Related]

  • 7. Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis.
    Riccitelli G, Rocca MA, Pagani E, Martinelli V, Radaelli M, Falini A, Comi G, Filippi M.
    Mult Scler; 2012 Jul 15; 18(7):1027-37. PubMed ID: 22422807
    [Abstract] [Full Text] [Related]

  • 8. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez de Mendizábal N, Toledo JB, Villoslada P.
    Arch Neurol; 2009 Feb 15; 66(2):173-9. PubMed ID: 19204153
    [Abstract] [Full Text] [Related]

  • 9. Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.
    Storelli L, Rocca MA, Pagani E, Van Hecke W, Horsfield MA, De Stefano N, Rovira A, Sastre-Garriga J, Palace J, Sima D, Smeets D, Filippi M, MAGNIMS Study GroupFrom the Neuroimaging Research Unit (L.S., M.A.R., E.P., M.F.) and Department of Neurology, Institute of Experimental Neurology, Division of Neuroscience (M.A.R., M.F.), San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Via Olgettina 60, 20132 Milan, Italy; Department of Research and Development, Icometrix, Leuven, Belgium (W.V.H., D. Sima, D. Smeets); Xinapse Systems, Colchester, England (M.A.H.); Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy (N.D.S.); Section of Neuroradiology, Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain (A.R.); Unit of Clinical Neuroimmunology, CEM-Cat, Hospital Universitari Vall d'Hebron, Barcelona, Spain (J.S.G.); and Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, England (J.P.)..
    Radiology; 2018 Aug 15; 288(2):554-564. PubMed ID: 29714673
    [Abstract] [Full Text] [Related]

  • 10. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
    Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone IL, Salvatore M, Bonavita V, Alfano B.
    Neurology; 2005 Jul 26; 65(2):280-5. PubMed ID: 16043800
    [Abstract] [Full Text] [Related]

  • 11. Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
    Fisher E, Nakamura K, Lee JC, You X, Sperling B, Rudick RA.
    Mult Scler; 2016 Apr 26; 22(5):668-76. PubMed ID: 26238463
    [Abstract] [Full Text] [Related]

  • 12. Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis.
    Bendfeldt K, Kappos L, Radue EW, Borgwardt SJ.
    J Neurol Sci; 2009 Oct 15; 285(1-2):268-9; author reply 269. PubMed ID: 19500803
    [No Abstract] [Full Text] [Related]

  • 13. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.
    Horakova D, Dwyer MG, Havrdova E, Cox JL, Dolezal O, Bergsland N, Rimes B, Seidl Z, Vaneckova M, Zivadinov R.
    J Neurol Sci; 2009 Jul 15; 282(1-2):112-9. PubMed ID: 19168190
    [Abstract] [Full Text] [Related]

  • 14. Segmentation of brain tissues using a 3-D multi-layer hidden Markov model.
    Foruzan AH, Kalantari Khandani I, Baradaran Shokouhi S.
    Comput Biol Med; 2013 Feb 15; 43(2):121-30. PubMed ID: 23261164
    [Abstract] [Full Text] [Related]

  • 15. Comparison of diffusion tensor imaging and voxel-based morphometry to detect white matter damage in Alzheimer's disease.
    Yoon B, Shim YS, Hong YJ, Koo BB, Kim YD, Lee KO, Yang DW.
    J Neurol Sci; 2011 Mar 15; 302(1-2):89-95. PubMed ID: 21168157
    [Abstract] [Full Text] [Related]

  • 16. Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy.
    Steenwijk MD, Amiri H, Schoonheim MM, de Sitter A, Barkhof F, Pouwels PJW, Vrenken H.
    Neuroimage Clin; 2017 Mar 15; 15():843-853. PubMed ID: 28794970
    [Abstract] [Full Text] [Related]

  • 17. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
    Gaetano L, Häring DA, Radue EW, Mueller-Lenke N, Thakur A, Tomic D, Kappos L, Sprenger T.
    Neurology; 2018 Apr 10; 90(15):e1324-e1332. PubMed ID: 29540589
    [Abstract] [Full Text] [Related]

  • 18. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC, Cerasa A, Liguori M, Passamonti L, Condino F, Vercillo L, Valentino P, Clodomiro A, Quattrone A, Fera F.
    Brain Res; 2007 Sep 05; 1167():71-9. PubMed ID: 17689504
    [Abstract] [Full Text] [Related]

  • 19. Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis.
    Zivadinov R, Grop A, Sharma J, Bratina A, Tjoa CW, Dwyer M, Zorzon M.
    J Neuroimaging; 2005 Jan 05; 15(1):27-36. PubMed ID: 15574571
    [Abstract] [Full Text] [Related]

  • 20. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
    Biberacher V, Schmidt P, Keshavan A, Boucard CC, Righart R, Sämann P, Preibisch C, Fröbel D, Aly L, Hemmer B, Zimmer C, Henry RG, Mühlau M.
    Neuroimage; 2016 Nov 15; 142():188-197. PubMed ID: 27431758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.